Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares.Maximize Your ...

TD Cowen analyst Dan Brennan lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps a Hold rating on the shares. The ...

Genomics (TXG) delivered earnings and revenue surprises of -25% and 0.03%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

PLEASANTON, Calif. AP) — 10x Genomics Inc. TXG) on Wednesday reported a loss of $49 million in its fourth quarter.

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Genomics is the study of the full genetic complement of an organism (the genome). It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the ...

The number of area high schools partnering with HudsonAlpha Wiregrass in a peanut breeding program jumped to 10 with the ...

Comparative genomics deals with the processes of evolution via the alignment and analysis of genes and genomes of living or extinct organisms related by varying degrees of evolutionary divergence ...

Red is the rarest hair color, but to understand why that’s the case, you need a basic grasp of the science. There’s a lot ...

Canadians deserve access to sexual and reproductive health services and resources that are safe, accurate and stigma-free. However, members of marginalized groups often experience barriers to care. By ...